`

REGENXBIO

Biotechnology Research

Specialities :
Biotechnology
Biopharmaceuticals
And gene therapy
Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$140.0M
size-icon Size
201 - 500
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About REGENXBIO

What does Regenxbio do?+

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIOs AAV Therapeutic platform, including Novartis ZOLGENSMA for children with spinal...

What are Regenxbio's specialties? +

Biotechnology,biopharmaceuticals,and gene therapy

What is Regenxbio's industry? +

Regenxbio operates in the Biotechnology research industry.

What is Regenxbio's revenue? +

Regenxbio's revenue is 11m - 100m

What is Regenxbio's company size? +

Regenxbio has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free